Clinical Trial Update: PET Imaging of Intracranial Cancers With 18F-FSPG [Phase 1]

View source ↗

Summary

Phase 1 study evaluating PET imaging of intracranial cancers with the radiotracer 18F-FSPG has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer

Drugs mentioned

• 18F-FSPG

Snippet

Sponsor: Life Molecular Imaging SA | Conditions: Brain Cancer | Phase 1 | Status: TERMINATED